DashBio

Boston, United States · Founded 2024 · $47.5M raised

Headquarters
Boston
Employees
11–50
Founded
2024
Business Model
B2B
Website
dash.bio
Total Funding
$47.5M
Last Round
$30.0M Series AAug 2026
Rounds
3

About

Dash Bio is a tech-first bioanalysis CRO built from day one around AI, robotics, and modern software rather than the traditional manual, error-prone bioanalysis model. Operating from its Boston headquarters, the company delivers sample analysis results in days instead of weeks, publishes pricing directly on its site for full transparency, and has raised $17.5M in funding to accelerate drug development timelines for biotech sponsors.

Summary

DashBio is a Biotech company based in Boston, United States, founded in 2024. It has raised $47.5M in total across 3 rounds, most recently a $30.0M Series A round in Aug 2026. Investors include Freestyle Capital, Oak HC/FT and The Aligned Fund.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AAug 2026
$30.0M

Sign up to see all 3 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

DashBio on Indexed.vc
<a href="https://indexed.vc/companies/dashbio"><img src="https://indexed.vc/api/badge/company/dashbio" alt="DashBio on Indexed.vc" width="260" height="76" /></a>